Such enzyme prodrug therapy, based on engineered and immunoisolated E. coli, may ultimately yield an improved therapeutic index relative to monotherapy, as AMF mediated hyperthermia might be expected to pre-sensitize tumors to chemotherapy under appropriate conditions.
Determination of process conditions for a fluid dispensing process of microchip encapsulation is a highly skilled task, which is usually based on engineers' knowledge and intuitive sense acquired through long-term experience rather than on a theoretical and analytical approach.
The findings suggest that the visualization of the dam layout, components and geometry within 3D settings overlaid with sensor data (which could be queried based on engineers' discipline-specific needs) and data analytics results provide a better flexibility to engineers to understand the risk associated with potential failure modes.
This review highlights some of the most recent developments in the field, focusing especially on devices based on engineered nanoparticles and ordered mesoporous silica thin films, and discussing their interest in designing sensors and biosensors for improved electrochemical detection.
A portable biosensor device, based on engineered yeast and bacterial cells fused to a reporter gene expressing luciferase, was reported to be able to detect several endocrine disruptors, including androgens and estrogens [ 53].
We present here recent developments in approaches, based on engineered peptides, proteins and biomaterials, that harness mechanisms of peripheral tolerance both prophylactically and therapeutically to induce antigen-specific immunological tolerance.
In addition, the results propose some antecedents of career orientation, mainly based on engineer needs, competencies and values, which may be moderated by some external factors, including organizational and national level phenomena.
Indeed, several processes based on engineered microorganisms, especially yeast and bacteria species, have been developed and implemented [ 123].
Recently new processes, based on engineered catalysts for asymmetric ketone reduction and reductive aminations, have been established and highlighted the potential for greener synthesis routes.
New gene-editing technologies such as CRISPR have sped the development of new crop varieties and animals, but products based on engineered organisms sometimes face a web of complex and overlapping regulations before they can reach the market.
